Please read the disclaimer below regarding this webpage and Pershing Square Holdings, Ltd. (the “Company”) carefully. You must accept its terms before you can proceed.

Users of this webpage are responsible for observing all applicable laws and regulations in their relevant jurisdictions before proceeding to access the information contained herein. By proceeding to access the information, users are deemed to have represented and warranted that the applicable laws and regulations of their relevant jurisdiction allow them to do so. No information contained on this webpage constitutes or would be deemed to constitute an invitation in any jurisdiction to invest or otherwise deal in the shares of the Company.

None of the information contained in this webpage constitutes an offer to sell, or a solicitation of an offer to buy or subscribe for, any shares or other securities to the public.

None of the information contained in this webpage constitutes an offer to sell, or a solicitation of an offer to buy or subscribe for, any shares or other securities in the United States or in any other jurisdiction, nor shall it, or the fact of its distribution, form the basis of, or be relied upon, in connection with or act as an inducement to enter into any contract or commitment therefor.

Shares may not be purchased by an “employee benefit plan” within the meaning of the U.S. Employee Retirement Income Security Act of 1974, as amended (“ERISA”), including (i) an investor using assets of: (A) an “employee benefit plan” as defined in Section 3(3) of ERISA that is subject to Title I of ERISA; (B) a “plan” as defined in Section 4975 of the U.S. Internal Revenue Code, as amended (the “IRC”), including an individual retirement account or other arrangement that is subject to Section 4975 of the IRC; or (C) an entity which is deemed to hold the assets of any of the foregoing types of plans, accounts or arrangements that is subject to Title I of ERISA or Section 4975 of the IRC.

The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the “Investment Company Act”), and investors will not be entitled to the benefits of that Act.

In addition, the shares in the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”). Consequently, shares in the Company may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, “U.S. persons” as defined in Regulation S under the Securities Act absent registration or an exemption from registration under the Securities Act. No public offering of any shares in the Company is being, or has been, made in the United States.

The Company is a registered closed-ended investment scheme registered pursuant to the Protection of Investors (Bailiwick of Guernsey) Law, 1987, as amended and the Registered Collective Investment Scheme Rules 2008 issued by the Guernsey Financial Services Commission (the “Commission”). The Commission has not reviewed this disclaimer and takes no responsibility for the financial soundness of the Company or for the correctness of any of the statements made or opinions expressed with regard to it.

All investment is subject to risk. The value of the shares in the Company may go down as well as up. Past performance is no guarantee of future returns and there is no guarantee that the market price of the Company’s shares will fully reflect their underlying net asset value. There is also no guarantee that the Company’s investment objective will be achieved. Potential investors are advised to seek expert financial advice before making any investment decision and should be aware that they may not fully recover the amount invested.

A prospectus has been prepared in connection with the admission of the shares in the Company to listing and trading on Euronext in Amsterdam, the regulated market operated by Euronext Amsterdam N.V., and was approved by the Netherlands Authority for the Financial Markets (the “AFM”) on 2 October 2014 (the “Prospectus”). A Dutch supplement to the Prospectus has been prepared which contains specific information for retail investors in the Company in the Netherlands (the “Supplement”). The Prospectus and the Supplement are available on the Company’s website (www.pershingsquareholdings.com).

Neither the Company nor Pershing Square Capital Management, L.P. (“PSCM”), the investment manager of the Company, assumes any obligation to update the information contained in the Prospectus or the Supplement thereto, unless a new offering in the Company will be undertaken.

No Reliance

No representation or warranty (including liability towards third parties), expressed or implied, is made as to its accuracy, reliability or completeness by the Company, PSCM, Cadarn Capital, their respective affiliates and third parties that have provided information contained in this webpage. Opinions and any other contents expressed on this webpage are provided for your personal use and informational purposes only and are subject to change without notice. Nothing contained on this webpage constitutes investment, legal, tax or other advice and is not to be relied on in making an investment or other decision. You should obtain relevant and specific professional advice before making any investment decision.

The information and opinions contained in this webpage are provided without any warranty of any kind, either expressed or implied, to the fullest extent permissible pursuant to applicable law. None of the Company, PSCM, Cadarn Capital or any of their respective affiliates further assumes any responsibility for, and makes any warranties that, information and supplies contained on this webpage will be uninterrupted or error-free, that defects will be corrected, or that this webpage or the servers that make it available will be free of viruses or other harmful components.

Liability Waiver

You agree that under no circumstances, including, but not limited to, negligence, shall the Company, PSCM, Cadarn Capital or any third party that has provided information contained in this webpage or any of their respective affiliates be liable for any direct, special or consequential damages that result from the access or use of, or the inability to access or use, the materials on this webpage. This does not exclude or restrict any duty or liability the Company or PSCM has to its customers under the regulatory system in the Netherlands or Guernsey.

Linked Sites

With the exception of the Company’s website (www.pershingsquareholdings.com), neither the Company nor PSCM has reviewed any webpage linked to this webpage and neither the Company nor PSCM is responsible for the contents of off-site pages or any other webpages linked or linking to this webpage. If you follow any links off this webpage you do so at your own risk.

Links to this webpage may not be established without the prior written consent of the Company and PSCM.

Skip to content
  • Listed
  • Concentrated US Equities

Pershing Square Holdings, Ltd. (“PSH”) appointed Cadarn Capital in June 2023 to provide distribution and investor relations services.

PSH is an investment holding company structured as a closed-ended fund principally engaged in the business of acquiring and holding significant (but generally not controlling) positions in a concentrated number of large capitalisation companies. PSH’s objective is to maximise its long-term compound annual rate of growth in intrinsic value per share.

The substantial majority of the Company’s portfolio is typically allocated to 8 to 12 core holdings usually comprising liquid, listed large capitaliszation North American companies. The Investment Manager generally focuses on high-quality businesses, which it believes have limited downside and that generate predictable, recurring cash flow, and in certain cases seeks to catalyse managerial, operating and governance changes as levers to create substantial, enduring and long-term shareholder value.

The Investment Manager aims to manage risks through careful investment selection and portfolio construction, engaging in typically only one to three new core investments each year. The Investment Manager also engages in opportunistic asymmetric hedging strategies to mitigate market-related downside risk and to take advantage of asymmetric profit opportunities.

This communication is being provided by Cadarn Capital (“Cadarn”) on behalf of Pershing Square Holdings, Ltd (“PSH”). Pershing Square Capital Management, L.P. is the investment manager to PSH. Cadarn is not a current client or investor of PSCM or PSH,  but Cadarn personnel responsible for this engagement may be invested in PSH. In addition, Cadarn receives an annual cash fee for services from PSH in connection with the services it provides to PSH .  Because Cadarn is compensated for these services, and because its personnel may be invested in PSH, Cadarn and its personnel have a conflict of interest when making an introduction to PSH.

Share
Fund Structures

Listed funds are investment vehicles traded on regulated exchanges, offering investors daily liquidity, transparent pricing, and ease of access. They are typically subject to exchange rules and ongoing disclosure requirements, making them suitable for a broad range of investors.

UCITS funds (Undertakings for Collective Investment in Transferable Securities) are a type of highly regulated investment fund in the European Union (EU) designed for retail investors.

Alternative investment funds provide access to assets such as private credit, infrastructure, or real assets, with limited or periodic liquidity. These funds are designed for longer-term strategies, offering diversification benefits beyond traditional listed markets.

Investor Portal

Exclusive access for professional investors

The Investor Portal provides professional investors with exclusive access to upcoming Cadarn events, detailed fund portfolio insights and associated fund materials. A dedicated information hub that offers an insight into our fund partners’ respective investment approaches, market insights and fund news.

Sign up

Cadarn Capital Ltd (FRN: 998015) is an appointed representative of Thornbridge Investment Management LLP (FRN: 713859) which is authorised and regulated by the Financial Conduct Authority